Zuvitere 20mg Injection
Marketer
Zuvius Life Sciences
Salt Composition
Docetaxel (20mg)
Overview Zuvitere 20mg Injection
Oncaspar 20mg Injection is a chemotherapy agent indicated for treating breast, non-small cell lung, prostate, and head and neck cancers. Administration is exclusively by injection from a qualified healthcare professional. Dosage and frequency are determined by your physician, based on your specific condition and may be adjusted. Adhere strictly to the prescribed regimen; incorrect usage or overdose can lead to severe adverse events. Therapeutic effects may not be apparent for weeks or months; discontinue only upon your doctor's instruction. Common side effects include shortness of breath, constipation, swelling, infections, appetite loss, myalgia, nail abnormalities, pain, and fatigue. Your doctor may prescribe additional medication to mitigate these. Report any unexplained bleeding or bruising, sore throat, mouth sores, or fever immediately. This medication can lower blood cell counts (red and white blood cells), increasing infection risk. Regular blood tests to monitor blood cell levels and liver function are essential. Prior to commencement, disclose any pre-existing heart, liver, or kidney conditions, and all medications, particularly anti-infectives, as interactions are possible. This medication is contraindicated during pregnancy and lactation; reliable contraception is crucial for both partners throughout treatment.
Uses of Zuvitere 20mg Injection
Cancers of the breast, lung (non-small cell), prostate, and head and neck.
Major Benefits of Zuvitere 20mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Zuvitere 20mg Injection:
- Breathlessness
- Constipation
- Edema (swelling)
- Infection
- Loss of appetite
- Muscle pain
- Nail disorder
- Pain
- Weakness
How to use Zuvitere 20mg Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strictly prohibited.
How Zuvitere 20mg Injection works:
Oncaspar 20mg Injection is a cancer treatment that disrupts the microtubule networks essential for cancer cell division and proliferation. This action inhibits cancer cell growth, ultimately leading to their demise.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Zuvitere 20mg Injection is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Administering Zuvitere 20mg Injection during pregnancy is contraindicated due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might consider its use only if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Zuvitere 20mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from the medication.
DrivingCONSULT YOUR DOCTOR
The impact of Zuvitere 20mg Injection on driving ability is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Zuvitere 20mg Injection is considered safe for administration. No alteration of the Zuvitere 20mg Injection dosage is necessary.
LiverCAUTION
Patients with liver impairment should use Zuvitere 20mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Zuvitere 20mg Injection :
NA
Facts to Know About Zuvitere 20mg Injection
| Label | Value |
|---|---|
| Chemical Type | Taxane-based Drugs |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Taxanes: Antimicrotubule Agents |
3,018 People bought this recently